Real-World Clinical Data for AI Models
Why synthetic data is not enough
Synthetic clinical data has value for prototyping and testing. It does not have value for training production clinical AI models. The reasons are fundamental:
- Distribution fidelity — synthetic generators cannot capture the full clinical distribution. Rare diseases, atypical presentations, treatment complications, and real-world confounders are systematically under-represented or absent.
- Temporal dynamics — real clinical data has longitudinal structure. A patient's lab values evolve over months. Treatments are started, adjusted, stopped. Synthetic data generators typically produce cross-sectional snapshots that lose this temporal signal.
- Clinical nuance — real clinical text contains implicit knowledge: severity modifiers, hedging language, clinical reasoning traces. Synthetic text generators produce plausible-sounding but medically shallow output.
- Validation gap — a model trained on synthetic data must still be validated on real data. If you cannot access real data for validation, synthetic training data provides false confidence.
What "real clinical data" means in practice
Real clinical data means data generated during actual care delivery:
- Imaging data — MRI, CT, X-ray, ultrasound, PET-CT, mammography produced during routine clinical workflows at NHS trusts and private imaging centres.
- Structured EHR data — lab results, vital signs, medication orders, diagnosis codes, procedure codes pulled from live Epic, Cerner, or Meditech instances.
- Unstructured clinical text — radiology reports, discharge summaries, clinic letters, operative notes, pathology reports written by actual clinicians for actual patients.
- Longitudinal outcomes — treatment response, readmission, mortality, complication rates tracked across months and years of real patient journeys.
How to access it without moving it
Rapha Protocol provides the technical bridge: researchers specify the dataset profile, modality, cohort criteria, and model architecture. The protocol routes the workload into the hospital environment where the data lives. Training executes locally. Researchers receive trained weights, metrics, and proof receipts — not raw data.
This is not a data marketplace. It is not a data broker. It is compute-to-data infrastructure. The researcher never downloads, stores, or processes raw clinical records. The hospital never exports, transfers, or sells patient data. The transaction is access to compute on data — not access to data itself.
Current early-access modalities
- Radiology imaging — MRI, CT, X-ray, ultrasound, mammography from NHS and private imaging providers.
- Structured EHR — lab results, vitals, diagnoses, medications from hospital EHR systems.
- Clinical text — radiology reports, discharge summaries for NLP and LLM fine-tuning.
- Genomics — genomic sequence and phenotype data for research workflows.
- Apple Health — patient-consented on-device health data (heart rate, sleep, HRV) through native iOS bridge.
Important: Rapha Protocol is private-alpha. Modality availability depends on configured hospital nodes. No claim is made that production hospital PHI has been processed through the public proof surface. The mainnet proof receipt demonstrates cryptographic infrastructure, not clinical data processing volume.